Clover Health officer proposes $1.31M share sale
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Clover Health Investments, Corp. (CLOV) reports that Officer Andrew Toy proposes to sell 309,558 shares of Class A common stock on approximately October 1, 2026, with an aggregate market value of $1,309,430.34. The shares are restricted stock units acquired from the issuer as compensation on October 1, 2026. The proposed sale is described as a sell-to-cover transaction to fund tax withholding tied to vesting and settlement, not a discretionary transaction; the Rule 10b5-1 plan was adopted March 2, 2026.
During the prior three months, sales under the plan included 313,476 shares on July 1, 2026, for gross proceeds of $1,667,692.32; 62,711 shares on July 15, 2026, for $292,860.37; and 87,798 shares on August 10, 2026, for $408,260.70.
Key Figures
Key Terms
restricted stock units financial
sell to cover financial
Rule 10b5-1 plan regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.